Skip to main content
. 2017 Oct 24;17:95. doi: 10.1186/s12935-017-0466-y

Fig. 3.

Fig. 3

MiR-1296-5p is down-regulated in ERBB2-positive breast cancer tissues. The miR-1296-5p expression is suppressed in a majority of ERBB2-positive breast cancer samples (n = 40) when compared to ERBB2-negative breast cancer samples (n = 74). The miRNA relative expression levels were normalized to the average value of ERBB2-positive breast cancer samples